Terrence F. Blaschke, MD

Terrence F. Blaschke is Professor of Medicine and Molecular Pharmacology (Active Emeritus) at Stanford University, Adjunct Professor of Biopharmaceutical Sciences at UCSF, and Adjunct Professor of Medicine at Indiana University. Dr. Blaschke received his medical degree from Columbia University and did his residency training in Internal Medicine at UCLA. Following fellowship training in Clinical Pharmacology at the University of California, San Francisco, he joined the faculty at Stanford University in 1974. Dr. Blaschke is a past president of the American Society for Clinical Pharmacology and Therapeutics (ASCPT). He is the recipient of the Rawls-Palmer award, the Henry W Elliott award, and the Oscar B. Hunter award from ASCPT. He has been a consultant and past Chair of the Generic Drugs Advisory Committee of the US FDA and of the Nonprescription Drugs Advisory Committee. He chaired the Drug Utilization Review Panel of USP from 1995-2000. He is also a consultant to a number of pharmaceutical firms and served on the Board of Directors of Therapeutic Discovery Corporation of Palo Alto, Crescendo Pharmaceuticals, in Mountain View, California and is now a director of DURECT Corporation in Cupertino, California. He was a member of the AIDS Clinical Trials Group (ACTG) at its inception, and has served as chair of the Pharmacology Committee and a member of the Executive Committee of the ACTG. His research has been primarily in the area of clinical investigation, with a focus on the clinical pharmacology of drugs used in patients with HIV infection and an emphasis on modeling exposure-response relationships and adherence. His involvement in clinical trials and with the pharmaceutical industry has also lead to a strong interest in approaches to improve the efficiency of the drug development process. Dr. Blaschke has over 170 original publications in peer reviewed journals and is an Associate Editor of the Annual Review of Pharmacology and Toxicology.